Comparing two forms of the pain medicine parecoxib
Treatments studied
Part of Pain clinical trials.
This trial compares two forms of the pain reliever parecoxib in healthy volunteers to see if they work the same in the body. It requires participants to be fasting and have no major health issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 20 and 45 years old.
- Your body mass index (BMI) is between 18 and 27.
- You have no major health problems (heart, liver, kidney, etc.) and are not on any regular medications.
- You are not allergic to parecoxib or similar drugs.
- You agree to use birth control if you are a woman of childbearing age, and are not pregnant or breastfeeding.
- You have not donated blood recently and are willing to avoid certain drugs and vaccines before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether parecoxib or indomethacin works better at preventing pancreatitis, a common complication after a procedure called ERCP. Participants will receive one of the two medicines before the procedure, and the study will track which one is safer and more effective.
This trial compares two pain relievers, Dynastat and Parestat, to see which works better for women after breast biopsy surgery. It may help you have less pain after your procedure.
This trial tests a pain medicine called parecoxib (injected into a vein) for people who have had a bleeding stroke around the brain (subarachnoid hemorrhage). It aims to see if it helps with pain without causing serious side effects.
This trial tests a new drug combination (DW-1021) against two common pain medications (Pelubi CR and Zytram CR) taken separately. Participation helps researchers understand how the drugs compare in healthy men.
This trial tests if a non-steroidal anti-inflammatory drug (parecoxib) works as well as morphine for treating sickle cell pain crises in the emergency room. The goal is to find a safer pain relief option for people with sickle cell disease.
This study tests two different versions of a drug called Trimedat to see if they work the same way in the body. It is for healthy volunteers to understand how the drug is absorbed and if it is safe.
Hear when a new Post Operative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.